Amgen, Inc.
All Topics
Find news about people
Find news on alumni of any org
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Amgen, Inc.
... years. Mr. Zindrick joined Genelux Corporation in May 2014 after retiring from Amgen, Inc. where he built his 16-year career. He has also served as ...
... TNF inhibitors market in Asia Pacific. AbbVie, Inc., Janssen Biotech, Inc., UCB, Amgen, Inc., were leaders of the TNF inhibitors Market in 2017 Key players ...
... technologies, including D-Wave Systems, Intel Corp., International Business Machines Corp., Microsoft, and Amgen Inc. Companies Mentioned 1Qbit Information Technologies Inc.Accenture LlpAdvancing Quantum Architecture (Aqua) GroupAirbus ...
... Amgen has broken ground on a next-generation biomanufacturing plant at its West Greenwich ...
... and a weak showing when on the market. Back in October 2015, Amgen gained FDA approval for the first oncolytic virus-based drug, Imlygic (talimogene laherparepvec), ...
... The board of directors of Amgen (NASDAQ:AMGN) approved a dividend of USD1.32 per share of the company's stock ...
... extensive competitive analysis and profiles of the key market players, such as Amgen, Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La ...
... Amgen's head of R&D, Sean Harper, announced he is stepping down from the ...
Subscribe now for full coverage on Amgen, Inc.
Start My Free Trial